| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |